speb/financial-data huggingface dataset:
CMG.TO balance_sheet (quarterly, 2025-09-30) — Capital Stock: 95851000.00
CMG.TO balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 32839000.00
CMG.TO balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 32839000.00
CMG.TO cash_flow (quarterly, 2025-09-30) — Cash Dividends Paid: -825000.00
CMG.TO balance_sheet (quarterly, 2025-09-30) — Cash Financial: 32839000.00
CMG.TO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -998000.00
CMG.TO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -9836000.00
CMG.TO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -2057000.00
CMG.TO cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: -1045000.00
CMG.TO cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: -3716000.00
CMG.TO cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: 233000.00
CMG.TO cash_flow (quarterly, 2025-09-30) — Change In Receivables: -1117000.00
CMG.TO cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -5645000.00
CMG.TO cash_flow (quarterly, 2025-09-30) — Changes In Cash: -12891000.00
CMG.TO balance_sheet (quarterly, 2025-09-30) — Common Stock: 95851000.00
CMG.TO cash_flow (quarterly, 2025-09-30) — Common Stock Dividend Paid: -825000.00
CMG.TO balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 89633000.00
CMG.TO cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 616000.00
CMG.TO income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 5542000.00
CMG.TO balance_sheet (quarterly, 2025-09-30) — Current Assets: 69820000.00
CMG.TO balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 2429000.00
CMG.TO balance_sheet (quarterly, 2025-09-30) — Current Debt: 327000.00
CMG.TO balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 2756000.00
CMG.TO balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 34615000.00
CMG.TO balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 34615000.00
CMG.TO balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 53034000.00
CMG.TO cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: -152000.00
CMG.TO cash_flow (quarterly, 2025-09-30) — Deferred Tax: -152000.00
CMG.TO cash_flow (quarterly, 2025-09-30) — Depreciation: 1093000.00
CMG.TO cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 2551000.00
CMG.TO cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 2551000.00
CMG.TO income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 84980000.00
CMG.TO income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.03
CMG.TO income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 2716000.00
CMG.TO income_statement (quarterly, 2025-09-30) — EBIT: 4830000.00
CMG.TO income_statement (quarterly, 2025-09-30) — EBITDA: 7381000.00
CMG.TO cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: 1704000.00
CMG.TO cash_flow (quarterly, 2025-09-30) — End Cash Position: 32839000.00
CMG.TO cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -998000.00
CMG.TO balance_sheet (quarterly, 2025-09-30) — Foreign Currency Translation Adjustments: 5646000.00
CMG.TO cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -3137000.00
CMG.TO income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: -691000.00
CMG.TO balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: 5646000.00
CMG.TO income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 6126000.00
CMG.TO balance_sheet (quarterly, 2025-09-30) — Goodwill: 19137000.00
CMG.TO balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 83622000.00
CMG.TO balance_sheet (quarterly, 2025-09-30) — Gross PPE: 38556000.00
CMG.TO income_statement (quarterly, 2025-09-30) — Gross Profit: 24659000.00
CMG.TO cash_flow (quarterly, 2025-09-30) — Income Tax Paid Supplemental Data: 3190000.00
CMG.TO balance_sheet (quarterly, 2025-09-30) — Income Tax Payable: 1161000.00
CMG.TO income_statement (quarterly, 2025-09-30) — Interest Expense: 466000.00
CMG.TO income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 466000.00
CMG.TO income_statement (quarterly, 2025-09-30) — Interest Income: 214000.00
CMG.TO income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 214000.00
CMG.TO cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 466000.00
CMG.TO balance_sheet (quarterly, 2025-09-30) — Invested Capital: 91186000.00
CMG.TO cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -9836000.00
CMG.TO cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 616000.00
CMG.TO balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 33778000.00
CMG.TO balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 1226000.00
CMG.TO balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 35004000.00
CMG.TO cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -619000.00
CMG.TO cash_flow (quarterly, 2025-09-30) — Net Business Purchase And Sale: -5174000.00
CMG.TO cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 616000.00
CMG.TO cash_flow (quarterly, 2025-09-30) — Net Foreign Currency Exchange Gain Loss: -342000.00
CMG.TO income_statement (quarterly, 2025-09-30) — Net Income: 2716000.00
CMG.TO income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 2716000.00
CMG.TO income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 2716000.00
CMG.TO income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 2716000.00
CMG.TO income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 2716000.00
CMG.TO cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 2716000.00
CMG.TO income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 2716000.00
CMG.TO income_statement (quarterly, 2025-09-30) — Net Interest Income: -252000.00
CMG.TO cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -619000.00
CMG.TO cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: -619000.00
CMG.TO income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -252000.00
CMG.TO cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -170000.00
CMG.TO cash_flow (quarterly, 2025-09-30) — Net Other Investing Changes: -3582000.00
CMG.TO balance_sheet (quarterly, 2025-09-30) — Net PPE: 38556000.00
CMG.TO cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -1080000.00
CMG.TO balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 6011000.00
CMG.TO balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Assets: 418000.00
CMG.TO balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 14540000.00
CMG.TO balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 418000.00
CMG.TO balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 14540000.00
CMG.TO income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 7946000.00
CMG.TO income_statement (quarterly, 2025-09-30) — Normalized Income: 3067636.11
CMG.TO cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -2057000.00
CMG.TO cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: -342000.00
CMG.TO income_statement (quarterly, 2025-09-30) — Operating Income: 5181000.00
CMG.TO income_statement (quarterly, 2025-09-30) — Operating Revenue: 30201000.00
CMG.TO balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 82727000.00
CMG.TO balance_sheet (quarterly, 2025-09-30) — Other Current Borrowings: 327000.00
CMG.TO income_statement (quarterly, 2025-09-30) — Other Gand A: 6126000.00
CMG.TO income_statement (quarterly, 2025-09-30) — Other Income Expense: -565000.00
CMG.TO balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 64485000.00
CMG.TO balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 170000.00
CMG.TO balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 375000.00
CMG.TO balance_sheet (quarterly, 2025-09-30) — Other Payable: 2336000.00
CMG.TO balance_sheet (quarterly, 2025-09-30) — Other Properties: 38556000.00
CMG.TO balance_sheet (quarterly, 2025-09-30) — Payables: 15663000.00
CMG.TO balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 15663000.00
CMG.TO balance_sheet (quarterly, 2025-09-30) — Prepaid Assets: 6093000.00
CMG.TO income_statement (quarterly, 2025-09-30) — Pretax Income: 4364000.00
CMG.TO cash_flow (quarterly, 2025-09-30) — Purchase Of Business: -5174000.00
CMG.TO cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -1080000.00
CMG.TO balance_sheet (quarterly, 2025-09-30) — Receivables: 30567000.00
CMG.TO income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 5542000.00
CMG.TO income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 2551000.00
CMG.TO cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -619000.00
CMG.TO income_statement (quarterly, 2025-09-30) — Research And Development: 7360000.00
CMG.TO balance_sheet (quarterly, 2025-09-30) — Restricted Cash: 321000.00
CMG.TO income_statement (quarterly, 2025-09-30) — Restructuring And Mergern Acquisition: -126000.00
CMG.TO balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -27663000.00
CMG.TO income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 5992000.00
CMG.TO income_statement (quarterly, 2025-09-30) — Selling General And Administration: 12118000.00
CMG.TO balance_sheet (quarterly, 2025-09-30) — Share Issued: 82727000.00
CMG.TO income_statement (quarterly, 2025-09-30) — Special Income Charges: 126000.00
CMG.TO cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: -1185000.00
CMG.TO balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 89633000.00
CMG.TO balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 6011000.00
CMG.TO income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: -213363.89
CMG.TO income_statement (quarterly, 2025-09-30) — Tax Provision: 1648000.00
CMG.TO income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.38
CMG.TO balance_sheet (quarterly, 2025-09-30) — Total Assets: 192586000.00
CMG.TO balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 90859000.00
CMG.TO balance_sheet (quarterly, 2025-09-30) — Total Debt: 37760000.00
CMG.TO balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 89633000.00
CMG.TO income_statement (quarterly, 2025-09-30) — Total Expenses: 25020000.00
CMG.TO balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 102953000.00
CMG.TO balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 122766000.00
CMG.TO balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 49919000.00
CMG.TO income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: 5181000.00
CMG.TO balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 1161000.00
CMG.TO income_statement (quarterly, 2025-09-30) — Total Unusual Items: -565000.00
CMG.TO income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -565000.00
CMG.TO balance_sheet (quarterly, 2025-09-30) — Working Capital: 16786000.00
CMG.TO income_statement (quarterly, 2025-12-31) — +Operating Expense: 19491000.00
CMG.TO income_statement (quarterly, 2025-12-31) — +Total Revenue: 32685000.00
CMG.TO balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 16321000.00
CMG.TO balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 40323000.00
CMG.TO balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 15977000.00
CMG.TO cash_flow (quarterly, 2025-12-31) — Amortization Cash Flow: 1484000.00
CMG.TO cash_flow (quarterly, 2025-12-31) — Amortization Of Intangibles: 1484000.00
CMG.TO income_statement (quarterly, 2025-12-31) — Basic Average Shares: 82957000.00
CMG.TO income_statement (quarterly, 2025-12-31) — Basic EPS: 0.07
CMG.TO cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 32839000.00
CMG.TO cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -723000.00
CMG.TO balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 35835000.00
CMG.TO balance_sheet (quarterly, 2025-12-31) — Capital Stock: 94773000.00
CMG.TO balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 20040000.00
CMG.TO balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 23740000.00
CMG.TO cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: -823000.00
CMG.TO balance_sheet (quarterly, 2025-12-31) — Cash Financial: 20040000.00
CMG.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -6541000.00
CMG.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -4423000.00
CMG.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 5000.00
CMG.TO cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: -2970000.00
CMG.TO cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 5441000.00
CMG.TO cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: 63000.00
CMG.TO cash_flow (quarterly, 2025-12-31) — Change In Receivables: -9597000.00
CMG.TO cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -7063000.00
CMG.TO cash_flow (quarterly, 2025-12-31) — Changes In Cash: -10959000.00
CMG.TO balance_sheet (quarterly, 2025-12-31) — Common Stock: 94773000.00
CMG.TO cash_flow (quarterly, 2025-12-31) — Common Stock Dividend Paid: -823000.00
CMG.TO balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 87335000.00
CMG.TO cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 0.00
CMG.TO cash_flow (quarterly, 2025-12-31) — Common Stock Payments: -6024000.00
CMG.TO income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 5975000.00
CMG.TO balance_sheet (quarterly, 2025-12-31) — Current Assets: 70607000.00
CMG.TO balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 2480000.00
CMG.TO balance_sheet (quarterly, 2025-12-31) — Current Debt: 322000.00
CMG.TO balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 2802000.00
CMG.TO balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 31992000.00
CMG.TO balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 31992000.00
CMG.TO balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 54156000.00
CMG.TO cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: -883000.00
CMG.TO cash_flow (quarterly, 2025-12-31) — Deferred Tax: -883000.00
CMG.TO cash_flow (quarterly, 2025-12-31) — Depreciation: 1157000.00
CMG.TO cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 2641000.00
CMG.TO cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 2641000.00
CMG.TO income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 82957000.00
CMG.TO income_statement (quarterly, 2025-12-31) — Diluted EPS: 0.07
CMG.TO income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 5964000.00
CMG.TO income_statement (quarterly, 2025-12-31) — EBIT: 7995000.00
CMG.TO income_statement (quarterly, 2025-12-31) — EBITDA: 10636000.00
CMG.TO cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: -1840000.00
CMG.TO cash_flow (quarterly, 2025-12-31) — End Cash Position: 20040000.00
CMG.TO cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -6541000.00
CMG.TO balance_sheet (quarterly, 2025-12-31) — Foreign Currency Translation Adjustments: 4098000.00
CMG.TO cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -718000.00
CMG.TO income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: 414000.00
CMG.TO balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 4098000.00
CMG.TO income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 6743000.00
CMG.TO balance_sheet (quarterly, 2025-12-31) — Goodwill: 18887000.00
CMG.TO balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 81222000.00
CMG.TO balance_sheet (quarterly, 2025-12-31) — Gross PPE: 38306000.00
CMG.TO income_statement (quarterly, 2025-12-31) — Gross Profit: 26710000.00
CMG.TO cash_flow (quarterly, 2025-12-31) — Income Tax Paid Supplemental Data: 3375000.00
CMG.TO balance_sheet (quarterly, 2025-12-31) — Income Tax Payable: 804000.00
CMG.TO income_statement (quarterly, 2025-12-31) — Interest Expense: 528000.00
CMG.TO income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 528000.00
CMG.TO income_statement (quarterly, 2025-12-31) — Interest Income: 362000.00
CMG.TO income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 362000.00
CMG.TO cash_flow (quarterly, 2025-12-31) — Interest Paid Supplemental Data: 528000.00
CMG.TO balance_sheet (quarterly, 2025-12-31) — Invested Capital: 90864000.00
CMG.TO cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -4423000.00
CMG.TO cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 0.00
CMG.TO cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 2000000.00
CMG.TO balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 33355000.00
CMG.TO balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 3207000.00
CMG.TO balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 36562000.00
CMG.TO cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: 2000000.00
CMG.TO cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -539000.00
CMG.TO cash_flow (quarterly, 2025-12-31) — Net Business Purchase And Sale: 0.00
CMG.TO cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: -6024000.00
CMG.TO cash_flow (quarterly, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: -841000.00
CMG.TO income_statement (quarterly, 2025-12-31) — Net Income: 5964000.00
CMG.TO income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 5964000.00
CMG.TO income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 5964000.00
CMG.TO income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 5964000.00
CMG.TO income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 5964000.00
CMG.TO cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 5964000.00
CMG.TO income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 5964000.00
CMG.TO income_statement (quarterly, 2025-12-31) — Net Interest Income: -166000.00
CMG.TO cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: -3700000.00
CMG.TO cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: 1461000.00
CMG.TO cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: 1461000.00
CMG.TO income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -166000.00
CMG.TO cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -1155000.00
CMG.TO balance_sheet (quarterly, 2025-12-31) — Net PPE: 38306000.00
CMG.TO cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -723000.00
CMG.TO balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 6113000.00
CMG.TO balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Assets: 938000.00
CMG.TO balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 13987000.00
CMG.TO balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Assets: 938000.00
CMG.TO balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 13987000.00
CMG.TO income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 10222000.00
CMG.TO income_statement (quarterly, 2025-12-31) — Normalized Income: 5633332.26
CMG.TO cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 5000.00
CMG.TO cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: -841000.00
CMG.TO income_statement (quarterly, 2025-12-31) — Operating Income: 7219000.00
CMG.TO income_statement (quarterly, 2025-12-31) — Operating Revenue: 32685000.00
CMG.TO balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 81574000.00
CMG.TO balance_sheet (quarterly, 2025-12-31) — Other Current Borrowings: 322000.00
CMG.TO income_statement (quarterly, 2025-12-31) — Other Gand A: 6743000.00
CMG.TO income_statement (quarterly, 2025-12-31) — Other Income Expense: 414000.00
CMG.TO balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 62335000.00
CMG.TO balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 1325000.00
CMG.TO balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 358000.00
CMG.TO balance_sheet (quarterly, 2025-12-31) — Other Payable: 2237000.00
CMG.TO balance_sheet (quarterly, 2025-12-31) — Other Properties: 38306000.00
CMG.TO balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 3700000.00
CMG.TO balance_sheet (quarterly, 2025-12-31) — Payables: 19362000.00
CMG.TO balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 19362000.00
CMG.TO balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 5900000.00
CMG.TO income_statement (quarterly, 2025-12-31) — Pretax Income: 7467000.00
CMG.TO cash_flow (quarterly, 2025-12-31) — Purchase Of Business: 0.00
CMG.TO cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -3700000.00
CMG.TO cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -723000.00
CMG.TO balance_sheet (quarterly, 2025-12-31) — Receivables: 40323000.00
CMG.TO income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 5975000.00
CMG.TO income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 2641000.00
CMG.TO cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -539000.00
CMG.TO cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: -6024000.00
CMG.TO income_statement (quarterly, 2025-12-31) — Research And Development: 8222000.00
CMG.TO balance_sheet (quarterly, 2025-12-31) — Restricted Cash: 644000.00
CMG.TO income_statement (quarterly, 2025-12-31) — Restructuring And Mergern Acquisition: 0.00
CMG.TO balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -27513000.00
CMG.TO income_statement (quarterly, 2025-12-31) — Selling And Marketing Expense: 4526000.00
CMG.TO income_statement (quarterly, 2025-12-31) — Selling General And Administration: 11269000.00
CMG.TO balance_sheet (quarterly, 2025-12-31) — Share Issued: 81574000.00
CMG.TO income_statement (quarterly, 2025-12-31) — Special Income Charges: 0.00
CMG.TO cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 187000.00
CMG.TO balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 87335000.00
CMG.TO balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 6113000.00
CMG.TO income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 83332.26
CMG.TO income_statement (quarterly, 2025-12-31) — Tax Provision: 1503000.00
CMG.TO income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.20
CMG.TO balance_sheet (quarterly, 2025-12-31) — Total Assets: 192398000.00
CMG.TO balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 90542000.00
CMG.TO balance_sheet (quarterly, 2025-12-31) — Total Debt: 39364000.00
CMG.TO balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 87335000.00
CMG.TO income_statement (quarterly, 2025-12-31) — Total Expenses: 25466000.00
CMG.TO balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 105063000.00
CMG.TO balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 121791000.00
CMG.TO balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 50907000.00
CMG.TO income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: 7219000.00
CMG.TO balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 804000.00
CMG.TO income_statement (quarterly, 2025-12-31) — Total Unusual Items: 414000.00
CMG.TO income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 414000.00
CMG.TO balance_sheet (quarterly, 2025-12-31) — Working Capital: 16451000.00
CMG.TO income_statement (annual, 2026-03-31) — +Operating Expense: 76113000.00
CMG.TO income_statement (quarterly, 2026-03-31) — +Operating Expense: 18762000.00
CMG.TO income_statement (annual, 2026-03-31) — +Total Revenue: 126189000.00
CMG.TO income_statement (quarterly, 2026-03-31) — +Total Revenue: 33670000.00
CMG.TO balance_sheet (annual, 2026-03-31) — Accounts Payable: 1756000.00
CMG.TO balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 1756000.00
CMG.TO balance_sheet (annual, 2026-03-31) — Accounts Receivable: 29159000.00
CMG.TO balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 29159000.00
CMG.TO balance_sheet (annual, 2026-03-31) — Accumulated Depreciation: -29963000.00
CMG.TO balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -29963000.00
CMG.TO balance_sheet (annual, 2026-03-31) — Additional Paid In Capital: 15922000.00
CMG.TO balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 15922000.00
CMG.TO cash_flow (annual, 2026-03-31) — Amortization Cash Flow: 5776000.00
CMG.TO cash_flow (quarterly, 2026-03-31) — Amortization Cash Flow: 1480000.00
CMG.TO cash_flow (annual, 2026-03-31) — Amortization Of Intangibles: 5776000.00
CMG.TO cash_flow (quarterly, 2026-03-31) — Amortization Of Intangibles: 1480000.00
CMG.TO cash_flow (annual, 2026-03-31) — Beginning Cash Position: 43884000.00
CMG.TO cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 20040000.00
CMG.TO balance_sheet (annual, 2026-03-31) — Buildings And Improvements: 38352000.00
CMG.TO balance_sheet (quarterly, 2026-03-31) — Buildings And Improvements: 38352000.00
CMG.TO cash_flow (annual, 2026-03-31) — Capital Expenditure: -2560000.00
CMG.TO cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -215000.00
CMG.TO balance_sheet (annual, 2026-03-31) — Capital Lease Obligations: 35205000.00
CMG.TO balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 35205000.00
CMG.TO balance_sheet (annual, 2026-03-31) — Capital Stock: 91453000.00
CMG.TO balance_sheet (quarterly, 2026-03-31) — Capital Stock: 91453000.00
CMG.TO balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 24100000.00
CMG.TO balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 24100000.00
CMG.TO balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 27800000.00
CMG.TO balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 27800000.00
CMG.TO cash_flow (annual, 2026-03-31) — Cash Dividends Paid: -6569000.00
CMG.TO cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: -792000.00
CMG.TO balance_sheet (annual, 2026-03-31) — Cash Financial: 24100000.00
CMG.TO balance_sheet (quarterly, 2026-03-31) — Cash Financial: 24100000.00
CMG.TO cash_flow (annual, 2026-03-31) — Cash Flow From Continuing Financing Activities: -23577000.00
CMG.TO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -11517000.00
CMG.TO cash_flow (annual, 2026-03-31) — Cash Flow From Continuing Investing Activities: -27108000.00
CMG.TO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -12306000.00
CMG.TO cash_flow (annual, 2026-03-31) — Cash Flow From Continuing Operating Activities: 31269000.00
CMG.TO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 26729000.00
CMG.TO cash_flow (annual, 2026-03-31) — Change In Other Working Capital: -6800000.00
CMG.TO cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: 5473000.00
CMG.TO cash_flow (annual, 2026-03-31) — Change In Payables And Accrued Expense: -2924000.00
CMG.TO cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -2382000.00
CMG.TO cash_flow (annual, 2026-03-31) — Change In Prepaid Assets: -801000.00
CMG.TO cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: -548000.00
CMG.TO cash_flow (annual, 2026-03-31) — Change In Receivables: 15913000.00
CMG.TO cash_flow (quarterly, 2026-03-31) — Change In Receivables: 14478000.00
CMG.TO cash_flow (annual, 2026-03-31) — Change In Working Capital: 5388000.00
CMG.TO cash_flow (quarterly, 2026-03-31) — Change In Working Capital: 17021000.00
CMG.TO cash_flow (annual, 2026-03-31) — Changes In Cash: -19416000.00
CMG.TO cash_flow (quarterly, 2026-03-31) — Changes In Cash: 2906000.00
CMG.TO balance_sheet (annual, 2026-03-31) — Common Stock: 91453000.00
CMG.TO balance_sheet (quarterly, 2026-03-31) — Common Stock: 91453000.00
CMG.TO cash_flow (annual, 2026-03-31) — Common Stock Dividend Paid: -6569000.00
CMG.TO cash_flow (quarterly, 2026-03-31) — Common Stock Dividend Paid: -792000.00
CMG.TO balance_sheet (annual, 2026-03-31) — Common Stock Equity: 78331000.00
CMG.TO balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 78331000.00
CMG.TO cash_flow (annual, 2026-03-31) — Common Stock Issuance: 830000.00
CMG.TO cash_flow (quarterly, 2026-03-31) — Common Stock Issuance: 0.00
CMG.TO cash_flow (annual, 2026-03-31) — Common Stock Payments: -20508000.00
CMG.TO cash_flow (quarterly, 2026-03-31) — Common Stock Payments: -14484000.00
CMG.TO income_statement (annual, 2026-03-31) — Cost Of Revenue: 23031000.00
CMG.TO income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 5556000.00
CMG.TO balance_sheet (annual, 2026-03-31) — Current Accrued Expenses: 14993000.00
CMG.TO balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 14993000.00
CMG.TO balance_sheet (annual, 2026-03-31) — Current Assets: 64435000.00
CMG.TO balance_sheet (quarterly, 2026-03-31) — Current Assets: 64435000.00
CMG.TO balance_sheet (annual, 2026-03-31) — Current Capital Lease Obligation: 2549000.00
CMG.TO balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 2549000.00
CMG.TO balance_sheet (annual, 2026-03-31) — Current Debt: 320000.00
CMG.TO balance_sheet (quarterly, 2026-03-31) — Current Debt: 320000.00
CMG.TO balance_sheet (annual, 2026-03-31) — Current Debt And Capital Lease Obligation: 2869000.00
CMG.TO balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 2869000.00
CMG.TO balance_sheet (annual, 2026-03-31) — Current Deferred Liabilities: 39294000.00
CMG.TO balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 39294000.00
CMG.TO balance_sheet (annual, 2026-03-31) — Current Deferred Revenue: 39294000.00
CMG.TO balance_sheet (quarterly, 2026-03-31) — Current Deferred Revenue: 39294000.00
CMG.TO balance_sheet (annual, 2026-03-31) — Current Liabilities: 64200000.00
CMG.TO balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 64200000.00
CMG.TO cash_flow (annual, 2026-03-31) — Deferred Income Tax: -1048000.00
CMG.TO cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: 370000.00
CMG.TO cash_flow (annual, 2026-03-31) — Deferred Tax: -1048000.00
CMG.TO cash_flow (quarterly, 2026-03-31) — Deferred Tax: 370000.00
CMG.TO cash_flow (annual, 2026-03-31) — Depreciation: 4473000.00
CMG.TO cash_flow (quarterly, 2026-03-31) — Depreciation: 1161000.00
CMG.TO cash_flow (annual, 2026-03-31) — Depreciation Amortization Depletion: 10249000.00
CMG.TO cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 2641000.00
CMG.TO cash_flow (annual, 2026-03-31) — Depreciation And Amortization: 10249000.00
CMG.TO cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 2641000.00
CMG.TO income_statement (annual, 2026-03-31) — Diluted NI Availto Com Stockholders: 17416000.00
CMG.TO income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 5427000.00
CMG.TO income_statement (annual, 2026-03-31) — EBIT: 26224000.00
CMG.TO income_statement (quarterly, 2026-03-31) — EBIT: 8699000.00
CMG.TO income_statement (annual, 2026-03-31) — EBITDA: 36473000.00
CMG.TO income_statement (quarterly, 2026-03-31) — EBITDA: 11340000.00
CMG.TO cash_flow (annual, 2026-03-31) — Effect Of Exchange Rate Changes: -368000.00
CMG.TO cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: 1154000.00
CMG.TO cash_flow (annual, 2026-03-31) — End Cash Position: 24100000.00
CMG.TO cash_flow (quarterly, 2026-03-31) — End Cash Position: 24100000.00
CMG.TO cash_flow (annual, 2026-03-31) — Financing Cash Flow: -23577000.00
CMG.TO cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -11517000.00
CMG.TO balance_sheet (annual, 2026-03-31) — Foreign Currency Translation Adjustments: 5386000.00
CMG.TO balance_sheet (quarterly, 2026-03-31) — Foreign Currency Translation Adjustments: 5386000.00
CMG.TO cash_flow (annual, 2026-03-31) — Free Cash Flow: 28709000.00
CMG.TO cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 26514000.00
CMG.TO income_statement (annual, 2026-03-31) — Gain On Sale Of Security: -1909000.00
CMG.TO income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: -725000.00
CMG.TO balance_sheet (annual, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: 5386000.00
CMG.TO balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: 5386000.00
CMG.TO income_statement (annual, 2026-03-31) — General And Administrative Expense: 24228000.00
CMG.TO income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 5620000.00
CMG.TO balance_sheet (annual, 2026-03-31) — Goodwill: 25032000.00
CMG.TO balance_sheet (quarterly, 2026-03-31) — Goodwill: 25032000.00
CMG.TO balance_sheet (annual, 2026-03-31) — Goodwill And Other Intangible Assets: 93908000.00
CMG.TO balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 93908000.00
CMG.TO balance_sheet (annual, 2026-03-31) — Gross PPE: 67390000.00
CMG.TO balance_sheet (quarterly, 2026-03-31) — Gross PPE: 67390000.00
CMG.TO income_statement (annual, 2026-03-31) — Gross Profit: 103158000.00
CMG.TO income_statement (quarterly, 2026-03-31) — Gross Profit: 28114000.00
CMG.TO cash_flow (annual, 2026-03-31) — Income Tax Paid Supplemental Data: 10503000.00
CMG.TO cash_flow (quarterly, 2026-03-31) — Income Tax Paid Supplemental Data: 2159000.00
CMG.TO balance_sheet (annual, 2026-03-31) — Income Tax Payable: 2280000.00
CMG.TO balance_sheet (quarterly, 2026-03-31) — Income Tax Payable: 2280000.00
CMG.TO income_statement (annual, 2026-03-31) — Interest Expense: 2090000.00
CMG.TO income_statement (quarterly, 2026-03-31) — Interest Expense: 622000.00
CMG.TO income_statement (annual, 2026-03-31) — Interest Expense Non Operating: 2090000.00
CMG.TO income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 622000.00
CMG.TO income_statement (annual, 2026-03-31) — Interest Income: 962000.00
CMG.TO income_statement (quarterly, 2026-03-31) — Interest Income: 72000.00
CMG.TO income_statement (annual, 2026-03-31) — Interest Income Non Operating: 962000.00
CMG.TO income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 72000.00
CMG.TO cash_flow (annual, 2026-03-31) — Interest Paid Supplemental Data: 1887000.00
CMG.TO cash_flow (quarterly, 2026-03-31) — Interest Paid Supplemental Data: 419000.00
CMG.TO balance_sheet (annual, 2026-03-31) — Invested Capital: 86398000.00
CMG.TO balance_sheet (quarterly, 2026-03-31) — Invested Capital: 86398000.00
CMG.TO cash_flow (annual, 2026-03-31) — Investing Cash Flow: -27108000.00
CMG.TO cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -12306000.00
CMG.TO cash_flow (annual, 2026-03-31) — Issuance Of Capital Stock: 830000.00
CMG.TO cash_flow (quarterly, 2026-03-31) — Issuance Of Capital Stock: 0.00
CMG.TO cash_flow (annual, 2026-03-31) — Issuance Of Debt: 10077000.00
CMG.TO cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 8077000.00
CMG.TO balance_sheet (annual, 2026-03-31) — Leases: 15467000.00
CMG.TO balance_sheet (quarterly, 2026-03-31) — Leases: 15467000.00
CMG.TO balance_sheet (annual, 2026-03-31) — Long Term Capital Lease Obligation: 32656000.00
CMG.TO balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 32656000.00
CMG.TO balance_sheet (annual, 2026-03-31) — Long Term Debt: 7747000.00
CMG.TO balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 7747000.00
CMG.TO balance_sheet (annual, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 40403000.00
CMG.TO balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 40403000.00
CMG.TO cash_flow (annual, 2026-03-31) — Long Term Debt Issuance: 10077000.00
CMG.TO cash_flow (quarterly, 2026-03-31) — Long Term Debt Issuance: 8077000.00
CMG.TO cash_flow (annual, 2026-03-31) — Long Term Debt Payments: -6082000.00
CMG.TO cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -4318000.00
CMG.TO balance_sheet (annual, 2026-03-31) — Machinery Furniture Equipment: 13571000.00
CMG.TO balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 13571000.00
CMG.TO cash_flow (annual, 2026-03-31) — Net Business Purchase And Sale: -17266000.00
CMG.TO cash_flow (quarterly, 2026-03-31) — Net Business Purchase And Sale: -8509000.00
CMG.TO cash_flow (annual, 2026-03-31) — Net Common Stock Issuance: -19678000.00
CMG.TO cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: -14484000.00
CMG.TO cash_flow (annual, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: 281000.00
CMG.TO cash_flow (quarterly, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: 1438000.00
CMG.TO income_statement (annual, 2026-03-31) — Net Income: 17416000.00
CMG.TO income_statement (quarterly, 2026-03-31) — Net Income: 5427000.00
CMG.TO income_statement (annual, 2026-03-31) — Net Income Common Stockholders: 17416000.00
CMG.TO income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 5427000.00
CMG.TO income_statement (annual, 2026-03-31) — Net Income Continuous Operations: 17416000.00
CMG.TO income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 5427000.00
CMG.TO income_statement (annual, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 17416000.00
CMG.TO income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 5427000.00
CMG.TO income_statement (annual, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 17416000.00
CMG.TO income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 5427000.00
CMG.TO cash_flow (annual, 2026-03-31) — Net Income From Continuing Operations: 17416000.00
CMG.TO cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 5427000.00
CMG.TO income_statement (annual, 2026-03-31) — Net Income Including Noncontrolling Interests: 17416000.00
CMG.TO income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 5427000.00
CMG.TO income_statement (annual, 2026-03-31) — Net Interest Income: -1128000.00
CMG.TO income_statement (quarterly, 2026-03-31) — Net Interest Income: -550000.00
CMG.TO cash_flow (annual, 2026-03-31) — Net Investment Purchase And Sale: -3700000.00
CMG.TO cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: 0.00
CMG.TO cash_flow (annual, 2026-03-31) — Net Issuance Payments Of Debt: 3995000.00
CMG.TO cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: 3759000.00
CMG.TO cash_flow (annual, 2026-03-31) — Net Long Term Debt Issuance: 3995000.00
CMG.TO cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: 3759000.00
CMG.TO income_statement (annual, 2026-03-31) — Net Non Operating Interest Income Expense: -1128000.00
CMG.TO income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -550000.00
CMG.TO cash_flow (annual, 2026-03-31) — Net Other Financing Charges: -1325000.00
CMG.TO cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: 0.00
CMG.TO cash_flow (annual, 2026-03-31) — Net Other Investing Changes: -3582000.00
CMG.TO balance_sheet (annual, 2026-03-31) — Net PPE: 37427000.00
CMG.TO balance_sheet (quarterly, 2026-03-31) — Net PPE: 37427000.00
CMG.TO cash_flow (annual, 2026-03-31) — Net PPE Purchase And Sale: -2560000.00
CMG.TO cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -215000.00
CMG.TO balance_sheet (annual, 2026-03-31) — Net Tangible Assets: -15577000.00
CMG.TO balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: -15577000.00
CMG.TO balance_sheet (annual, 2026-03-31) — Non Current Deferred Assets: 212000.00
CMG.TO balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Assets: 212000.00
CMG.TO balance_sheet (annual, 2026-03-31) — Non Current Deferred Liabilities: 13534000.00
CMG.TO balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 13534000.00
CMG.TO balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Assets: 212000.00
CMG.TO balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 212000.00
CMG.TO balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Liabilities: 13534000.00
CMG.TO balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 13534000.00
CMG.TO income_statement (annual, 2026-03-31) — Normalized EBITDA: 38256000.00
CMG.TO income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 12065000.00
CMG.TO income_statement (annual, 2026-03-31) — Normalized Income: 18702679.70
CMG.TO income_statement (quarterly, 2026-03-31) — Normalized Income: 5914133.22
CMG.TO cash_flow (annual, 2026-03-31) — Operating Cash Flow: 31269000.00
CMG.TO cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 26729000.00
CMG.TO cash_flow (annual, 2026-03-31) — Operating Gains Losses: 281000.00
CMG.TO cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: 1438000.00
CMG.TO income_statement (annual, 2026-03-31) — Operating Income: 27045000.00
CMG.TO income_statement (quarterly, 2026-03-31) — Operating Income: 9352000.00
CMG.TO income_statement (annual, 2026-03-31) — Operating Revenue: 126189000.00
CMG.TO income_statement (quarterly, 2026-03-31) — Operating Revenue: 33670000.00
CMG.TO balance_sheet (annual, 2026-03-31) — Ordinary Shares Number: 78340000.00
CMG.TO balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 78340000.00
CMG.TO balance_sheet (annual, 2026-03-31) — Other Current Borrowings: 320000.00
CMG.TO balance_sheet (quarterly, 2026-03-31) — Other Current Borrowings: 320000.00
CMG.TO income_statement (annual, 2026-03-31) — Other Gand A: 24228000.00
CMG.TO income_statement (quarterly, 2026-03-31) — Other Gand A: 5620000.00
CMG.TO income_statement (annual, 2026-03-31) — Other Income Expense: -1783000.00
CMG.TO income_statement (quarterly, 2026-03-31) — Other Income Expense: -725000.00
CMG.TO balance_sheet (annual, 2026-03-31) — Other Intangible Assets: 68876000.00
CMG.TO balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 68876000.00
CMG.TO cash_flow (annual, 2026-03-31) — Other Non Cash Items: -126000.00
CMG.TO balance_sheet (annual, 2026-03-31) — Other Non Current Assets: 1324000.00
CMG.TO balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 1324000.00
CMG.TO balance_sheet (annual, 2026-03-31) — Other Non Current Liabilities: 838000.00
CMG.TO balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 838000.00
CMG.TO balance_sheet (annual, 2026-03-31) — Other Payable: 3008000.00
CMG.TO balance_sheet (quarterly, 2026-03-31) — Other Payable: 3008000.00
CMG.TO balance_sheet (annual, 2026-03-31) — Other Short Term Investments: 3700000.00
CMG.TO balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 3700000.00
CMG.TO balance_sheet (annual, 2026-03-31) — Payables: 7044000.00
CMG.TO balance_sheet (quarterly, 2026-03-31) — Payables: 7044000.00
CMG.TO balance_sheet (annual, 2026-03-31) — Payables And Accrued Expenses: 22037000.00
CMG.TO balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 22037000.00
CMG.TO balance_sheet (annual, 2026-03-31) — Prepaid Assets: 7330000.00
CMG.TO balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 7330000.00
CMG.TO income_statement (annual, 2026-03-31) — Pretax Income: 24134000.00
CMG.TO income_statement (quarterly, 2026-03-31) — Pretax Income: 8077000.00
CMG.TO balance_sheet (annual, 2026-03-31) — Properties: 0.00
CMG.TO balance_sheet (quarterly, 2026-03-31) — Properties: 0.00
CMG.TO cash_flow (annual, 2026-03-31) — Purchase Of Business: -17266000.00
CMG.TO cash_flow (quarterly, 2026-03-31) — Purchase Of Business: -8509000.00
CMG.TO cash_flow (annual, 2026-03-31) — Purchase Of Investment: -3700000.00
CMG.TO cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: 0.00
CMG.TO cash_flow (annual, 2026-03-31) — Purchase Of PPE: -2560000.00
CMG.TO cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -215000.00
CMG.TO balance_sheet (annual, 2026-03-31) — Receivables: 29159000.00
CMG.TO balance_sheet (quarterly, 2026-03-31) — Receivables: 29159000.00
CMG.TO income_statement (annual, 2026-03-31) — Reconciled Cost Of Revenue: 23031000.00
CMG.TO income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 5556000.00
CMG.TO income_statement (annual, 2026-03-31) — Reconciled Depreciation: 10249000.00
CMG.TO income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 2641000.00
CMG.TO cash_flow (annual, 2026-03-31) — Repayment Of Debt: -6082000.00
CMG.TO cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -4318000.00
CMG.TO cash_flow (annual, 2026-03-31) — Repurchase Of Capital Stock: -20508000.00
CMG.TO cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: -14484000.00
CMG.TO income_statement (annual, 2026-03-31) — Research And Development: 32459000.00
CMG.TO income_statement (quarterly, 2026-03-31) — Research And Development: 8844000.00
CMG.TO balance_sheet (annual, 2026-03-31) — Restricted Cash: 146000.00
CMG.TO balance_sheet (quarterly, 2026-03-31) — Restricted Cash: 146000.00
CMG.TO income_statement (annual, 2026-03-31) — Restructuring And Mergern Acquisition: -126000.00
CMG.TO income_statement (quarterly, 2026-03-31) — Restructuring And Mergern Acquisition: 0.00
CMG.TO balance_sheet (annual, 2026-03-31) — Retained Earnings: -34430000.00
CMG.TO balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -34430000.00
CMG.TO income_statement (annual, 2026-03-31) — Selling And Marketing Expense: 19426000.00
CMG.TO income_statement (quarterly, 2026-03-31) — Selling And Marketing Expense: 4298000.00
CMG.TO income_statement (annual, 2026-03-31) — Selling General And Administration: 43654000.00
CMG.TO income_statement (quarterly, 2026-03-31) — Selling General And Administration: 9918000.00
CMG.TO balance_sheet (annual, 2026-03-31) — Share Issued: 78340000.00
CMG.TO balance_sheet (quarterly, 2026-03-31) — Share Issued: 78340000.00
CMG.TO income_statement (annual, 2026-03-31) — Special Income Charges: 126000.00
CMG.TO income_statement (quarterly, 2026-03-31) — Special Income Charges: 0.00
CMG.TO cash_flow (annual, 2026-03-31) — Stock Based Compensation: -891000.00
CMG.TO cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: -42000.00
CMG.TO balance_sheet (annual, 2026-03-31) — Stockholders Equity: 78331000.00
CMG.TO balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 78331000.00
CMG.TO balance_sheet (annual, 2026-03-31) — Tangible Book Value: -15577000.00
CMG.TO balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: -15577000.00
CMG.TO income_statement (annual, 2026-03-31) — Tax Effect Of Unusual Items: -496320.30
CMG.TO income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: -237866.78
CMG.TO income_statement (annual, 2026-03-31) — Tax Provision: 6718000.00
CMG.TO income_statement (quarterly, 2026-03-31) — Tax Provision: 2650000.00
CMG.TO income_statement (annual, 2026-03-31) — Tax Rate For Calcs: 0.28
CMG.TO income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.33
CMG.TO balance_sheet (annual, 2026-03-31) — Total Assets: 197306000.00
CMG.TO balance_sheet (quarterly, 2026-03-31) — Total Assets: 197306000.00
CMG.TO balance_sheet (annual, 2026-03-31) — Total Capitalization: 86078000.00
CMG.TO balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 86078000.00
CMG.TO balance_sheet (annual, 2026-03-31) — Total Debt: 43272000.00
CMG.TO balance_sheet (quarterly, 2026-03-31) — Total Debt: 43272000.00
CMG.TO balance_sheet (annual, 2026-03-31) — Total Equity Gross Minority Interest: 78331000.00
CMG.TO balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 78331000.00
CMG.TO income_statement (annual, 2026-03-31) — Total Expenses: 99144000.00
CMG.TO income_statement (quarterly, 2026-03-31) — Total Expenses: 24318000.00
CMG.TO balance_sheet (annual, 2026-03-31) — Total Liabilities Net Minority Interest: 118975000.00
CMG.TO balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 118975000.00